Verition Fund Management’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$70.5M Buy
319,229
+318,357
+36,509% +$88.1M 0.36% 25
2026
Q1
$258K Sell
872
-15,824
-95% -$4.7M ﹤0.01% 1847
2025
Q4
$4.56M Sell
16,696
-9,572
-36% -$2.6M 0.02% 948
2025
Q3
$7.1M Buy
26,268
+9,277
+55% +$2.52M 0.03% 802
2025
Q2
$4.68M Sell
16,991
-79,383
-82% -$21.6M 0.02% 1177
2025
Q1
$25.6M Buy
96,374
+74,252
+336% +$18.3M 0.12% 150
2024
Q4
$5.14M Sell
22,122
-92,548
-81% -$21.3M 0.02% 877
2024
Q3
$25.3M Buy
114,670
+88,264
+334% +$18.3M 0.13% 130
2024
Q2
$5.19M Buy
26,406
+23,521
+815% +$4.86M 0.03% 709
2024
Q1
$621K Sell
2,885
-12,020
-81% -$2.52M ﹤0.01% 1894
2023
Q4
$3.14M Buy
14,905
+9,183
+160% +$1.96M 0.02% 626
2023
Q3
$1.15M Buy
5,722
+2,805
+96% +$558K 0.01% 1017
2023
Q2
$540K Sell
2,917
-1,641
-36% -$303K 0.01% 1193
2023
Q1
$873K Sell
4,558
-4,210
-48% -$761K 0.01% 997
2022
Q4
$1.47M Sell
8,768
-8,206
-48% -$1.43M 0.02% 753
2022
Q3
$3.01M Buy
16,974
+8,175
+93% +$1.62M 0.03% 668
2022
Q2
$1.8M Buy
8,799
+7,069
+409% +$1.5M 0.04% 720
2022
Q1
$411K Buy
+1,730
New +$406K ﹤0.01% 2001
2021
Q3
Sell
-2,651
Closed -$564K 1960
2021
Q2
$564K Buy
+2,651
New +$560K 0.01% 1042
2020
Q4
Sell
-2,636
Closed -$441K 1140
2020
Q3
$441K Sell
2,636
-3,101
-54% -$522K 0.01% 618
2020
Q2
$932K Buy
+5,737
New +$1.03M 0.03% 434
2020
Q1
Sell
-2,462
Closed -$494K 682
2019
Q4
$494K Buy
+2,462
New +$505K 0.01% 675
2019
Q2
Sell
-12,361
Closed -$2.03M 1102
2019
Q1
$2.03M Buy
12,361
+8,943
+262% +$1.58M 0.08% 197
2018
Q4
$643K Buy
+3,418
New +$631K 0.05% 373
2018
Q3
Sell
-1,508
Closed -$247K 1266
2018
Q2
$247K Sell
1,508
-14,454
-91% -$2.36M 0.02% 938
2018
Q1
$2.58M Buy
15,962
+6,583
+70% +$1.05M 0.19% 104
2017
Q4
$1.37M Buy
+9,379
New +$1.34M 0.13% 165
2017
Q3
Sell
-3,732
Closed -$467K 1177
2017
Q2
$467K Sell
3,732
-2,122
-36% -$254K 0.05% 451
2017
Q1
$695K Sell
5,854
-1,747
-23% -$210K 0.06% 404
2016
Q4
$877K Buy
+7,601
New +$846K 0.08% 316
2016
Q3
Sell
-3,919
Closed -$382K 1151
2016
Q2
$382K Buy
+3,919
New +$370K 0.05% 501
2016
Q1
Sell
-7,775
Closed -$704K 717
2015
Q4
$704K Buy
7,775
+5,602
+258% +$527K 0.13% 140
2015
Q3
$202K Buy
+2,173
New +$207K 0.05% 454
2014
Q3
Sell
-35,330
Closed -$2.51M 736
2014
Q2
$2.51M Buy
35,330
+31,920
+936% +$2.25M 0.27% 48
2014
Q1
$252K Buy
3,410
+521
+18% +$39.3K 0.04% 320
2013
Q4
$227K Buy
+2,889
New +$226K 0.04% 355
2013
Q3
Sell
-2,919
Closed -$222K 558
2013
Q2
$222K Buy
+2,919
New +$192K 0.04% 460

Other funds holding CME

Verition Fund Management's CME Position: Q2 2026 in Review

Verition Fund Management increased its CME Group (CME) stake by 36,509% in Q2 2026, buying an estimated $88.1M and bringing the position to 319,229 shares worth $70.5M. The position accounts for 0.36% of the portfolio, ranked #25.

Verition Fund Management first reported a position in CME in Q2 2013 and has held it in 37 quarters since. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Verition Fund Management held 319,229 shares of CME Group worth $70.5M as of Q2 2026.
  • Verition Fund Management bought 318,357 CME Group shares in Q2 2026, an estimated $88.1M.
  • CME Group made up 0.36% of Verition Fund Management's portfolio in Q2 2026, its #25 holding.
  • Verition Fund Management first reported a position in CME Group in Q2 2013 and has held it in 37 quarters since.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.